Report: Counties that spray the most glyphosate have higher non-Hodgkin lymphoma rates - Iowa Capital Dispatch
Report: Counties that spray the most glyphosate have higher non-Hodgkin lymphoma rates Iowa Capital Dispatch
Non-Hodgkin Lymphoma News
Report: Counties that spray the most glyphosate have higher non-Hodgkin lymphoma rates - Ottumwa Courier
Report: Counties that spray the most glyphosate have higher non-Hodgkin lymphoma rates Ottumwa Courier
Primary non-Hodgkin lymphoma in the muscle of left lower extremity: a case report and literature review - Frontiers
Primary non-Hodgkin lymphoma in the muscle of left lower extremity: a case report and literature review Frontiers
Analysis finds "hot spots" for glyphosate and cancer in Iowa and other Midwest states - The New Lede
Analysis finds "hot spots" for glyphosate and cancer in Iowa and other Midwest states The New Lede
New Analysis Maps Glyphosate, Cancer Connection - Food & Water Watch
New Analysis Maps Glyphosate, Cancer Connection Food & Water Watch
Miami F Marcus Allen has non-Hodgkin lymphoma, out for season - ESPN
Miami F Marcus Allen has non-Hodgkin lymphoma, out for season ESPN
Non-Hodgkin lymphoma survivor thankful for clinical trial - UT MD Anderson
Non-Hodgkin lymphoma survivor thankful for clinical trial UT MD Anderson
New long-term analysis suggests follicular lymphoma can be cured - Fred Hutchinson Cancer Center
New long-term analysis suggests follicular lymphoma can be cured Fred Hutchinson Cancer Center
A Rare Case of Non-Hodgkin Lymphoma of the Tracheobronchial Tree - Cureus
A Rare Case of Non-Hodgkin Lymphoma of the Tracheobronchial Tree Cureus
Levofloxacin for the prevention of febrile episodes in non-Hodgkin lymphoma patients treated with CHOP plus rituximab in a randomized controlled trial - Nature
Levofloxacin for the prevention of febrile episodes in non-Hodgkin lymphoma patients treated with CHOP plus rituximab in a randomized controlled trial Nature
Monsanto Roundup Lawsuit | March 2026 Update & Settlement - Lawsuit Information Center
Monsanto Roundup Lawsuit | March 2026 Update & Settlement Lawsuit Information Center
Axi-Cel Shows Durable Responses, Curative Hope in Non-Hodgkin Lymphoma - Targeted Oncology
Axi-Cel Shows Durable Responses, Curative Hope in Non-Hodgkin Lymphoma Targeted Oncology
Non-Hodgkin lymphoma and HIV - Aidsmap
Non-Hodgkin lymphoma and HIV Aidsmap
CAR-NK Shows Long-Term Response in Waldenström Non-Hodgkin Lymphoma - Cure Today
CAR-NK Shows Long-Term Response in Waldenström Non-Hodgkin Lymphoma Cure Today
Dave Coulier Reveals New Cancer Diagnosis Months After Beating Non-Hodgkin Lymphoma - People.com
Dave Coulier Reveals New Cancer Diagnosis Months After Beating Non-Hodgkin Lymphoma People.com
Primary Pulmonary Non-Hodgkin Lymphoma: A Report of Two Cases and a Review of the Literature Emphasizing the Role of Radiotherapy - Cureus
Primary Pulmonary Non-Hodgkin Lymphoma: A Report of Two Cases and a Review of the Literature Emphasizing the Role of Radiotherapy Cureus
Stage IV non-Hodgkin lymphoma survivor: Why I’m excited about UT MD Anderson coming to Austin - UT MD Anderson
Stage IV non-Hodgkin lymphoma survivor: Why I’m excited about UT MD Anderson coming to Austin UT MD Anderson
Hepatitis virus-associated B cell non-Hodgkin’s lymphoma involves dysregulated epigenetic and RNA-mediated regulatory gene expression and altered snoRNA transcription - Nature
Hepatitis virus-associated B cell non-Hodgkin’s lymphoma involves dysregulated epigenetic and RNA-mediated regulatory gene expression and altered snoRNA transcription Nature
Diffuse Gastrointestinal Polyposis Revealing Mantle Cell Lymphoma: A Case Highlighting a Diagnostic Pitfall - Cureus
Diffuse Gastrointestinal Polyposis Revealing Mantle Cell Lymphoma: A Case Highlighting a Diagnostic Pitfall Cureus
Transformation of Classical Hodgkin Lymphoma Into Non-Hodgkin Lymphoma: Three Case Reports From the West Bank - Wiley Online Library
Transformation of Classical Hodgkin Lymphoma Into Non-Hodgkin Lymphoma: Three Case Reports From the West Bank Wiley Online Library
Breast Mass as an Atypical Presentation of Non-Hodgkin Lymphoma - Cureus
Breast Mass as an Atypical Presentation of Non-Hodgkin Lymphoma Cureus
Axicabtagene Ciloleucel in Relapsed or Refractory Indolent Non-Hodgkin Lymphoma: 5-Year Follow-up of ZUMA-5 - The ASCO Post
Axicabtagene Ciloleucel in Relapsed or Refractory Indolent Non-Hodgkin Lymphoma: 5-Year Follow-up of ZUMA-5 The ASCO Post
Non-Hodgkin's Lymphoma in Pregnancy: A Report of a Rare Case - Cureus
Non-Hodgkin's Lymphoma in Pregnancy: A Report of a Rare Case Cureus
Cancer Drug Tazemetostat (Tazverik) Pulled Due to Safety Concerns - Oncology News Central
Cancer Drug Tazemetostat (Tazverik) Pulled Due to Safety Concerns Oncology News Central
Researchers Identify Predictors of Response to CAR T-Cell Therapy in B-Cell Non-Hodgkin’s Lymphoma - Cleveland Clinic
Researchers Identify Predictors of Response to CAR T-Cell Therapy in B-Cell Non-Hodgkin’s Lymphoma Cleveland Clinic
Non-Hodgkin Lymphoma and Tuberculosis Coexisting in the Same Cervical Lymph Node: A Case Report - Cureus
Non-Hodgkin Lymphoma and Tuberculosis Coexisting in the Same Cervical Lymph Node: A Case Report Cureus
Low-grade B-cell non-Hodgkin lymphoma in the sternocleidomastoid muscle: a case report and review of literature - Frontiers
Low-grade B-cell non-Hodgkin lymphoma in the sternocleidomastoid muscle: a case report and review of literature Frontiers
A Milky Mystery: Chylothorax Unmasking Non-Hodgkin Lymphoma - Cureus
A Milky Mystery: Chylothorax Unmasking Non-Hodgkin Lymphoma Cureus
Non-Hodgkin lymphoma survival rate: Outlook and more - Medical News Today
Non-Hodgkin lymphoma survival rate: Outlook and more Medical News Today
T-Cell Therapy EB103 Demonstrates Safety in B-Cell Non-Hodgkin Lymphoma - Targeted Oncology
T-Cell Therapy EB103 Demonstrates Safety in B-Cell Non-Hodgkin Lymphoma Targeted Oncology
Prolonged BTK Inhibitor Bridging Therapy Associated With Improved CAR T Response in Higher-Risk R/R DLBCL - OncLive
Prolonged BTK Inhibitor Bridging Therapy Associated With Improved CAR T Response in Higher-Risk R/R DLBCL OncLive
USMNT Legend Kasey Keller Opens Up About Non-Hodgkin Lymphoma Journey - Forbes
USMNT Legend Kasey Keller Opens Up About Non-Hodgkin Lymphoma Journey Forbes
Safety and efficacy of autologous humanized CD19 CAR-T cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma - Nature
Safety and efficacy of autologous humanized CD19 CAR-T cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma Nature
The ratio of brain to liver glucose activity and prognosis with CAR-T in non-Hodgkin lymphoma | Blood Cancer Journal - Nature
The ratio of brain to liver glucose activity and prognosis with CAR-T in non-Hodgkin lymphoma | Blood Cancer Journal Nature
Lymphocyte Kinetics After CAR T-Cell Infusion May Predict Survival Outcomes in Non-Hodgkin Lymphoma - The ASCO Post
Lymphocyte Kinetics After CAR T-Cell Infusion May Predict Survival Outcomes in Non-Hodgkin Lymphoma The ASCO Post
Health Spotlight | New therapy offers hope for non-Hodgkin’s lymphoma patients - WISH-TV
Health Spotlight | New therapy offers hope for non-Hodgkin’s lymphoma patients WISH-TV
New treatment combination offers excellent results for early-stage Hodgkin lymphoma with less chemotherapy - UT MD Anderson
New treatment combination offers excellent results for early-stage Hodgkin lymphoma with less chemotherapy UT MD Anderson
Dave Coulier Battling Tongue Cancer After Beating Non-Hodgkin Lymphoma - Rolling Stone
Dave Coulier Battling Tongue Cancer After Beating Non-Hodgkin Lymphoma Rolling Stone
Hurricanes' Marcus Allen diagnosed with non-Hodgkin lymphoma, will miss remainder of season - Yahoo Sports
Hurricanes' Marcus Allen diagnosed with non-Hodgkin lymphoma, will miss remainder of season Yahoo Sports
Computational screening and in vitro evaluation of sphingosine-1-phosphate analogues as therapeutics for Non-Hodgkin’s lymphoma - Nature
Computational screening and in vitro evaluation of sphingosine-1-phosphate analogues as therapeutics for Non-Hodgkin’s lymphoma Nature